Business December 21, 2020
SEC charges Decision Diagnostics, CEO Keith Berman with fraud over COVID-19 blood testing device
Decision Diagnostics Corp., a biotechnology company based in California, and its CEO Keith Berman, are facing fraud charges filed by…